Amyloid-β — a reflection of risk or a preclinical marker?

Research output: Contribution to journalArticle

3 Scopus citations


In a recent study, individuals with brain amyloid-β accumulation but no cognitive impairment were classified as being at risk of Alzheimer disease, yet amyloid-β is widely considered to be a pathological biomarker of Alzheimer disease rather than a risk factor — it cannot be both.

Original languageEnglish (US)
Pages (from-to)1-2
Number of pages2
JournalNature Reviews Neurology
StateAccepted/In press - Apr 30 2018


ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this